Deep Medicine
0772.322.413 · rovalta.com · 23/09/2026
Deep Medicine
Overview
What does Deep Medicine do?
Deep Medicine is a Private limited company incorporated in 2021. Its registered office is in Beveren-Kruibeke-Zwijndrecht.
9120 Beveren-Kruibeke-Zwijndrecht · FlandreSee on map
Trend over 4 financial years
| 2025 | 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Gross margin | -23,6 k € | -470% | 6,4 k € | +151% | -12,6 k € | +13.3% | -14,6 k € |
| EBITDA | -23,7 k € | -684% | 4,1 k € | +132% | -12,7 k € | +13.2% | -14,7 k € |
| Operating result | -26,7 k € | +45.3% | -48,7 k € | +24.6% | -64,6 k € | -5.9% | -61 k € |
| Net result | -27,9 k € | +44.8% | -50,6 k € | +23.9% | -66,4 k € | -4.1% | -63,8 k € |
| Balance sheet | |||||||
| Equity | -59,8 k € | -87.5% | -31,9 k € | -271% | 18,7 k € | -78.1% | 85,1 k € |
| Total assets | 177,9 k € | -9.7% | 196,9 k € | -16.1% | 234,8 k € | +0.5% | 233,5 k € |
| Cash | 3 k € | -84.6% | 19,2 k € | +432% | 3,6 k € | +78.8% | 2 k € |
| Debts | 237,7 k € | +3.9% | 228,9 k € | +5.9% | 216,1 k € | +45.6% | 148,5 k € |
Board of directors
Seen on filing of 31/12/2025 · 4 active · 2 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
247 Alpha● Active | 0804.732.289 |
247 Energy● Active | 0683.450.023 |
247 Omega● Active | 0805.973.592 |
Cartière● Active | 0761.994.584 |
CINERGY EUROPE● Active | 0668.726.908 |
Colman Capital● Active | 1003.625.742 |
MARCEL DE VOS & C°● Active | 0434.772.707 |
Venture Campus Management● Active | 1025.977.611 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 06/08/2021 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
| Length of the financial year | 12 months | 12 months | 12 months | 17 months |
| Filing date | 29/07/2026 | 15/07/2025 | 31/07/2024 | 28/07/2023 |
| General meeting | 26/06/2026 | 11/06/2025 | 15/05/2024 | 07/06/2023 |
| Currency of the financial year | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
4 filings with the NBB
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 4 active · 2 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-27,9 k €↑
- 2025Name changeDeep Medicine
- 2024Annual accounts 2024-50,6 k €↑
- 2023Annual accounts 2023-66,4 k €↓
- 2022Annual accounts 2022-63,8 k €
- 2022Name changeVitamin AI
- 06/08/2021IncorporationPrivate limited company